Anlnylam’s Brendan Martin joined the pharmaphorum podcast for episode 23 to talk about his company’s work in gene-silencing and how it could offer a route to target the current coronavirus pandemic.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
